Showing results (211-220 of 331) with videos related to
Sort By:
Pageof 34
Cancer Discovery|September 3, 2017
Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early AdaptationChunying Song, Marco Piva, Lu Sun, et al.Journal for Immunotherapy of Cancer|June 6, 2024
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanomaJoseph J Sacco, Richard D Carvajal, Marcus O Butler, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2022
Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant MelanomaMartin Schuler, Lisa Zimmer, Kevin B Kim, et al.Journal for Immunotherapy of Cancer|March 8, 2023
Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapyPrachi Bhave, Angela Hong, Serigne N Lo, et al.Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
irAE-GPT: Leveraging large language models to identify immune-related adverse events in electronic health records and clinical trial datasetsCosmin A Bejan, Michelle Wang, Sriram Venkateswaran, et al.JCO Oncology Practice|June 23, 2026
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 TherapyMegan Othus, Thach-Giao Truong, Elad Sharon, et al.Cancer Discovery|November 23, 2013
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapyHubing Shi, Willy Hugo, Xiangju Kong, et al.European Journal of Cancer (Oxford, England : 1990)|July 2, 2021
Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti-PD-1 therapyAdriana Hepner, Victoria G Atkinson, James Larkin, et al.Ebiomedicine|April 8, 2026
irAE-GPT: leveraging large language models to identify immune-related adverse events in electronic health records and clinical trial datasetsCosmin A Bejan, Michelle Wang, Sriram Venkateswaran, et al.Cancer Discovery|December 11, 2021
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and CancerArielle Elkrief, Julie T Wu, Chinmay Jani, et al.Pageof 34